Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alison K Lew"'
Autor:
Cynthia T. Nguyen, Rachel Baccile, Amanda M. Brown, Alison K. Lew, Jennifer Pisano, Natasha N. Pettit
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 4 (2024)
Abstract Background: The 2022 SHEA/IDSA/APIC guidance for surgical site infection (SSI) prevention recommends reserving vancomycin prophylaxis to patients who are methicillin-resistant Staphylococcus aureus (MRSA) colonized. Unfortunately, vancomyci
Externí odkaz:
https://doaj.org/article/2da4838b03e94d52a339acebececa866
Autor:
Natasha N. Pettit, Cynthia T. Nguyen, Alison K. Lew, Palak H. Bhagat, Allison Nelson, Gregory Olson, Jessica P. Ridgway, Mai T. Pho, Jade Pagkas-Bather
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Empiric antibiotics for community acquired bacterial pneumonia (CABP) are often prescribed to patients with COVID-19, despite a low reported incidence of co-infections. Stewardship interventions targeted at facilitating appropriat
Externí odkaz:
https://doaj.org/article/227211409b3f4a12bc4f4c8470784b72
Publikováno v:
Open Forum Infectious Diseases. 9
Background Historically, intravenous (IV) antibiotics have been the standard of care for the treatment of bloodstream infections (BSIs). IV antibiotic use predisposes patients to line-related complications and is associated with increased length of s
Publikováno v:
Open Forum Infectious Diseases. 9
Background Vancomycin is often initiated empirically in hospitalized patients for broad spectrum gram-positive coverage, however in many cases it is initiated unnecessarily and/or continued empirically for longer durations than necessary. Strategies
Autor:
Cynthia T Nguyen, Jennifer Pisano, Natasha N Pettit, Alison K Lew, Renslow Sherer, Aniruddha Hazra, Kathleen M. Mullane
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases
Clinical Infectious Diseases
BackgroundRemdesivir (RDV) is US FDA approved for coronavirus disease 2019 (COVID-19) but not recommended in severe renal impairment (SRI, Creatinine clearance MethodsHospitalized patients who received RDV between 1 May 2020 and 31 October 2020 were
Autor:
Cynthia T Nguyen, Jessica P Ridgway, Natasha N Pettit, Jade Pagkas-Bather, Palak B. Bhagat, Mai T. Pho, Allison Nelson, Alison K Lew, Gregory Olson
Background: Empiric antibiotics for community acquired bacterial pneumonia (CABP) are often prescribed to patients with COVID-19, despite a low reported incidence of co-infections. Stewardship interventions targeted at facilitating appropriate antibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f668365f2ffea17aab54f3d5127f0dd6
https://doi.org/10.21203/rs.3.rs-94854/v1
https://doi.org/10.21203/rs.3.rs-94854/v1
Autor:
Jessica P Ridgway, Jade Pagkas-Bather, Alison K Lew, Palak H. Bhagat, Natasha N Pettit, Allison Nelson, Mai T. Pho, Gregory Olson, Cynthia T Nguyen
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
Background Empiric antibiotics for community acquired bacterial pneumonia (CABP) are often prescribed to patients with COVID-19, despite a low reported incidence of co-infections. Stewardship interventions targeted at facilitating appropriate antibio
Autor:
David Pitrak, Jina Saltzman, Aniruddha Hazra, Alison K Lew, Mai T. Pho, Kenneth Pursell, Natasha N Pettit, Gregory Olson, Cynthia T Nguyen
Publikováno v:
Open Forum Infectious Diseases
There are many unknowns with regard to COVID-19 clinical management, including the role of Infectious Diseases Consultation (IDC). As hospitalizations for COVID-19 continue, hospitals are assessing how to optimally and efficiently manage COVID-19 inp
Autor:
Mohammad B. Ateya, Kristin C. Klein, Krishna Rao, Jerod Nagel, Alison K Lew, Alison C Tribble
Publikováno v:
Open Forum Infectious Diseases
Background Clostridium difficile infection (CDI) is associated with high rates of recurrence, and major risk factors for recurrence include prior CDI episode(s) and antibiotic exposure. Prior studies concluded a reduction in CDI recurrence using oral
Autor:
Mohammad B. Ateya, Jerod Nagel, Jefferson L Cua, Twisha S Patel, Vince Marshall, Keith S Kaye, Tejal N Gandhi, Lindsay A Petty, Gregory A. Eschenauer, Ryan L. Crass, Ji Baang, Carol E. Chenoweth, Alison K Lew
Publikováno v:
Open Forum Infectious Diseases
Background Pneumonia remains a leading cause of hospitalization and accounts for significant antibiotic use. This study aims to evaluate the impact of bundled antimicrobial stewardship program (ASP) interventions, including procalcitonin and surveill